Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statement of Changes in Shareholders' Equity

v3.23.3
Consolidated Statement of Changes in Shareholders' Equity - USD ($)
shares in Millions, $ in Millions
Total
Cumulative Effect, Period of Adoption, Adjustment
Preferred Stock
Common Stock and Additional Paid-in Capital
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Income (Loss)
Beginning balance at Dec. 31, 2021 $ 270,066   $ 24,708 $ 62,398 $ 188,064   $ (5,104)
Beginning balance (in shares) at Dec. 31, 2021       8,077.8      
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 20,396       20,396    
Net change in debt securities (6,381)           (6,381)
Net change in debit valuation adjustments 1,298           1,298
Net change in derivatives (10,890)           (10,890)
Employee benefit plan adjustments 97           97
Net change in foreign currency translation adjustments (47)           (47)
Dividends declared:              
Common (5,188)       (5,188)    
Preferred (1,285)       (1,285)    
Issuance of preferred stock 4,426   4,426        
Common stock issued under employee plans, net, and other 1,107     $ 1,137 (30)    
Common stock issued under employee plans, net, and other (in shares)       44.5      
Common stock repurchased (4,075)     $ (4,075)      
Common stock repurchased (in shares)       (97.8)      
Ending balance at Sep. 30, 2022 269,524   29,134 $ 59,460 201,957   (21,027)
Ending balance (in shares) at Sep. 30, 2022       8,024.5      
Beginning balance at Jun. 30, 2022 269,118   29,134 $ 59,499 197,159   (16,674)
Beginning balance (in shares) at Jun. 30, 2022       8,035.2      
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 7,082       7,082    
Net change in debt securities (1,112)           (1,112)
Net change in debit valuation adjustments 462           462
Net change in derivatives (3,703)           (3,703)
Employee benefit plan adjustments 37           37
Net change in foreign currency translation adjustments (37)           (37)
Dividends declared:              
Common (1,780)       (1,780)    
Preferred (503)       (503)    
Common stock issued under employee plans, net, and other 410     $ 411 (1)    
Common stock issued under employee plans, net, and other (in shares)       2.5      
Common stock repurchased (450)     $ (450)      
Common stock repurchased (in shares)       (13.2)      
Ending balance at Sep. 30, 2022 269,524   29,134 $ 59,460 201,957   (21,027)
Ending balance (in shares) at Sep. 30, 2022       8,024.5      
Beginning balance at Dec. 31, 2022 273,197 $ 184 28,397 $ 58,953 207,003 $ 184 (21,156)
Beginning balance (in shares) at Dec. 31, 2022       7,996.8      
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 23,371       23,371    
Net change in debt securities 81           81
Net change in debit valuation adjustments (419)           (419)
Net change in derivatives (317)           (317)
Employee benefit plan adjustments 25           25
Net change in foreign currency translation adjustments (6)           (6)
Dividends declared:              
Common (5,459)       (5,459)    
Preferred (1,343)       (1,343)    
Common stock issued under employee plans, net, and other 1,515     $ 1,522 (7)    
Common stock issued under employee plans, net, and other (in shares)       45.1      
Common stock repurchased (3,765)     $ (3,765)      
Common stock repurchased (in shares)       (118.5)      
Ending balance at Sep. 30, 2023 287,064   28,397 $ 56,710 223,749   (21,792)
Ending balance (in shares) at Sep. 30, 2023       7,923.4      
Beginning balance at Jun. 30, 2023 283,319   28,397 $ 57,267 218,397   (20,742)
Beginning balance (in shares) at Jun. 30, 2023       7,953.6      
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 7,802       7,802    
Net change in debt securities (642)           (642)
Net change in debit valuation adjustments (25)           (25)
Net change in derivatives (366)           (366)
Employee benefit plan adjustments 6           6
Net change in foreign currency translation adjustments (23)           (23)
Dividends declared:              
Common (1,919)       (1,919)    
Preferred (531)       (531)    
Common stock issued under employee plans, net, and other 443     $ 443      
Common stock issued under employee plans, net, and other (in shares)       2.3      
Common stock repurchased (1,000)     $ (1,000)      
Common stock repurchased (in shares)       (32.5)      
Ending balance at Sep. 30, 2023 $ 287,064   $ 28,397 $ 56,710 $ 223,749   $ (21,792)
Ending balance (in shares) at Sep. 30, 2023       7,923.4